Your browser doesn't support javascript.
Thromboembolic Complications in Severe COVID-19: Current Antithrombotic Strategies and Future Perspectives.
Rodriguez, Juan J; Munoz, Oscar C; Porres-Aguilar, Mateo; Mukherjee, Debabrata.
  • Rodriguez JJ; Facultad de Medicina, Universidad Autonoma Bucaramanga, Bucaramanga, Colombia.
  • Munoz OC; Department of Interventional Cardiology, Del Sol Medical Center, El Paso, TX 79925, United States.
  • Porres-Aguilar M; Division of Adult Thrombosis Medicine, Centre of Excellence in Thrombosis and Anticoagulation Care (CETAC) at Jewish General Hospital, Department of Medicine, McGill University, Montreal, Quebec, Canada.
  • Mukherjee D; Division of Cardiovascular Diseases, Department of Medicine, Texas Tech University Health Sciences Center at El Paso, El Paso, TX 79905, United States.
Cardiovasc Hematol Disord Drug Targets ; 21(1): 23-29, 2021.
Article in English | MEDLINE | ID: covidwho-1133783
ABSTRACT
The coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus (SARS- CoV-2) is our latest pandemic and has turned out to be a global public health crisis. One of the special characteristics of this disease is that it may predispose patients to thrombotic disease both in the venous and arterial circulation. We review arterial and venous thromboembolic complications in patients with COVID-19, epidemiology, pathogenesis, hematologic biomarkers, and current antithrombotic strategies. Future perspectives and clinical trials are ongoing to determine the best thromboprophylaxis strategies in the hospitalized patients with severe COVID-19.
Subject(s)
Keywords
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Thromboembolism / COVID-19 Type of study: Observational study / Prognostic study / Reviews Topics: Long Covid Limits: Humans Language: English Journal: Cardiovasc Hematol Disord Drug Targets Journal subject: Vascular Diseases / Cardiology / Hematology / Drug Therapy Year: 2021 Document Type: Article Affiliation country: 1871529X21666210315123347

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Thromboembolism / COVID-19 Type of study: Observational study / Prognostic study / Reviews Topics: Long Covid Limits: Humans Language: English Journal: Cardiovasc Hematol Disord Drug Targets Journal subject: Vascular Diseases / Cardiology / Hematology / Drug Therapy Year: 2021 Document Type: Article Affiliation country: 1871529X21666210315123347